Tracker › Companies › Emergent BioSolutions Inc.
3 No sign of it. We found no public evidence tying Emergent BioSolutions Inc.'s cuts to AI.
Every tracked 2026 layoff at Emergent BioSolutions Inc., newest first. Scores are 0–100: how strongly the public evidence ties the cuts to AI. Sources are linked on each one.
AI score 3/100 (Minimal) · 80% interval 2–4 · evidence grade D · MD · Pharma / Chemicals
Stated reason: On August 5, 2026, the Company announced an organizational restructuring plan (the “Restructuring Plan”) intended to strengthen its long-term financial position in response to changes in its business. These strategic actions will lead to a reduction of the Company’s current workforce by approximately 93 employees across all areas of the Company and the elimination of approximately 21 positions that are currently vaca…
Why 3: Plant, store or site closure · Drivers: contrary evidence −0.7, industry AI exposure +0.5
Evidence: SEC filing, state WARN notice. Signals: attribution 0.0, primary source 0.0, exec statement 0.0, role exposure 0.827, industry exposure 0.712, AI investment 0.0, contrary evidence 0.4 · named roles: Accountants and Auditors, Bookkeeping, Accounting, and Auditing Clerks, Purchasing Agents, Except Wholesale, Retail, and Farm Products
Headcount basis: 8-K text · WARN: 34 workers at 1 site notice(s)
Scores are evidence-based estimates from a published model, not findings that AI caused any layoff. Spot something wrong or missing? Tell us.
Other Health Care & Pharma layoffs we track.
Health Care & Pharma · 3,800 workers
Health Care & Pharma · 648 workers
Health Care & Pharma · 419 workers
Health Care & Pharma · 365 workers
Health Care & Pharma · 300 workers
Health Care & Pharma · 120 workers
